When in doubt, pig it out: a versatile translational platform to study CKD, HFpEF, and CKM syndrome

Alfonso Eirin1,2, Alejandro R Chade3,4,5

  • 1Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, United States.

Insights

New swine models accurately mimic human chronic kidney disease (CKD), heart failure with preserved ejection fraction (HFpEF), and cardiovascular-kidney-metabolic (CKM) syndrome. These models aid in understanding disease mechanisms and developing novel therapeutic interventions.

Area of Science:

  • Cardiovascular Science
  • Nephrology
  • Metabolic Disease Research

Background:

  • Chronic kidney disease (CKD), heart failure with preserved ejection fraction (HFpEF), and cardiovascular-kidney-metabolic (CKM) syndrome pose significant health challenges with high morbidity and mortality.
  • The complex pathophysiology of these conditions hinders effective prevention and treatment strategies.
  • Large animal models are crucial for elucidating cardio-renal pathophysiology and advancing therapeutic discovery.

Purpose of the Study:

  • To introduce and characterize novel swine models for CKD, HFpEF, and CKM syndrome.
  • To investigate the impact of biological variables like sex and age on these cardio-renal-metabolic conditions.
  • To identify key pathogenetic mechanisms and potential therapeutic targets.

Main Methods:

  • Development and characterization of specialized swine models.
  • Utilizing these models to study the impact of biological variables (sex, age) on disease progression.
  • Analyzing data to reveal underlying pathophysiological mechanisms.

Main Results:

  • Swine models closely recapitulate human CKD, HFpEF, and CKM syndrome.
  • These models facilitate the study of disease mechanisms and the influence of sex and age.
  • Key pathogenetic mechanisms and potential therapeutic targets were identified.

Conclusions:

  • Novel swine models provide a powerful platform for studying cardio-renal-metabolic diseases.
  • These models are instrumental in understanding disease pathogenesis and exploring new therapeutic avenues.
  • Future research using these models will focus on developing innovative treatments for CKD, HFpEF, and CKM syndrome.

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
580
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
734
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
500
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
414
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
218
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
573